Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/Fluticasone Powder vs Seretide in Asthma
NCT03461627Phase 3Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Apr 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate, salmeterol in asthma, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03461627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03461627.